ALAdam C. Lowe

Adam C. Lowe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam C. Lowe has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing the accuracy of predicted values of human CO2 generation rates for IAQ applications

    by Oluwatobi Oke, Rodrigo Fernández-Verdejo, Adam Lowe, Laura Watson, Shanshan Chen, Stefan Flagner, Guy Plaqui, Andrew Persily

  • Open Access

    Exercise Heart Rate Variability Suggests Parasympathetic Hyperactivity during Simulated Military Operations Irrespective of Testosterone Administration

    by Adam C. Lowe, Alexandra Niclou, Alyssa N. Varanoske, Melissa N. Harris, Callie Hebert, Neil M. Johannsen, Steven B. Heymsfield, Frank L. Greenway, Lee M. Margolis, Harris R. Lieberman, et al.

    Introduction: Heart rate variability (HRV), typically measured at rest, is a measure of autonomic balance sensitive to physical and psychological stress. Testosterone supplementation during multistressor military operations may maintain exercise HRV by preventing a decrease in cardiac autonomic tone. The purpose of this study was to assess exercise HRV as a marker of physiological and psychological stress and determine if testosterone administration maintains HRV during extended simulated military operations. Methods: Thirty-two physically active males were enrolled in this parallel arm, randomized, placebo-controlled, double-blind study. Participants were randomized to receive a single injection of testosterone undecanoate (TEST, n = 16) or an isovolumetric placebo (PLA, n = 16) and completed 20 d of simulated operations cycles comprised of low-stress and high-stress days. Simulated operations were comprised of 4 cycles of two low-stress days (LS, ~1000 kcal of exercise-induced energy expenditure [EIEE] and 8 h of sleep) and three high-stress days (HS, ~3000 kcal EIEE, 4 h of sleep). Heart rate was collected during daily load carriage (~30% of body weight) exercise between 0500 and 0800 h. Short-term exercise HRV during this load carriage exercise was assessed through standard deviation of normal-to-normal beats (SDNN), root-mean-square of successive differences (RMSSD) between normal heart beats, low-frequency (LF) and high-frequency (HF) heartbeat sequences, and the ratio of LF to HF (LF/HF). Results: SDNN and RMSSD increased from the first to the last LS day ( P = 0.018 and P = 0.003, respectively) and from the first to the last HS day ( P = 0.006 and P < 0.001, respectively). LF and HF also increased from the first to the last LS day ( P = 0.027 and P = 0.028, respectively) and from the first to the last HS day ( P = 0.004 and P = 0.002, respectively), whereas LF/HF was unchanged across these time points ( P = 0.800 and P = 0.643, respectively). TEST showed higher LF/HF ratio on LS days ( P = 0.006) and HS days ( P < 0.001) compared with PLA. Conclusions: Exercise HRV metrics suggested parasympathetic hyperactivity despite concomitant increases in stress across the extended simulated military operations. A single dose of TEST does not appear to negatively affect the autonomic response to high stress in young health physically active males.


  • Associations between physical activity, brain health, cognitive function, and circulating GPLD1 in healthy older (65–85 years) individuals

    by Kara L. Marlatt, Adam C. Lowe, Guillermo Sanchez-Delgado, Robbie A. Beyl, Matthew K. Viverito, Jeffrey N. Keller, Owen T. Carmichael, Eric Ravussin

    Declines in physical and cognitive function are common in older adults. The circulating enzyme glycosylphosphatidylinositol (GPI)-specific phospholipase D1 (GPLD1) is elevated after exercise and has been associated with improved cognitive function when administered to aged mice. The purpose of this study was to investigate the relationship between GPLD1 and both cognitive function and brain structure/function in older adults with either high or low levels of physical activity. Healthy men and women aged 65 to 85 years with a body mass index between 20 and 35 kg/m2 and a rapid assessment of physical activity score of 1–3 (inactive) or 6–7 (highly active) were recruited. Participants wore an accelerometer to assess objectively physical activity. At a single clinical visit, fasting blood was collected for assessment of circulating GPLD1 while cognitive function via the Mini-Mental State Exam and NIH Toolbox® Cognition Battery, and brain magnetic resonance imaging (MRI and fMRI) were completed. As expected, highly active participants had a higher number of steps and total minutes of moderate-to-vigorous physical activity over 7 days (both p = 0.003). However, no difference in GPLD1 was observed between highly active and inactive participants (p = 0.751). Cognitive function was also similar between groups. Higher circulating GPLD1 was associated with poorer processing speed (r = 0.461, p = 0.027) but tended to be associated with greater functional MRI activation of Attention Network Task alerting regions of interest (r = 0.391, p = 0.120). Unlike hypothesized, physical activity status did not determine circulating GPLD1. No clear relationship was found between GPLD1 and cognitive function or brain structure and function. ClinicalTrials.gov Identifier: NCT04645134 (Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1).


  • Changes in insulin sensitivity and gut peptides 8 and 52 weeks after bariatric surgery or low‐calorie diet

    by Adam C. Lowe, Dorien Reijnders, Charmaine S. Tam, Leanne M. Redman, Robbie Beyl, Karl A. LeBlanc, Mark G. Hausmann, Vance L. Albaugh, Frank L. Greenway, Eric Ravussin

    Summary: The endocrine consequences of weight loss by bariatric surgery (BS) and caloric restriction are not fully understood but contribute to variable improvements in insulin sensitivity and cardiometabolic health. This study compared changes in insulin sensitivity and plasma concentrations of gut peptides 8 weeks and 1 year after BS and a low‐calorie diet (LCD). Nineteen female patients with obesity self‐selected BS (gastric bypass [n = 5] or sleeve gastrectomy [n = 7]) or LCD (n = 7) in this parallel‐arm, prospective observational study. We assessed insulin sensitivity via a two‐step hyperinsulinemic–euglycemic clamp (20 and 80 mU/min/m2 insulin). Plasma glucose, insulin, and gut peptides were measured around a mixed meal tolerance test (400 kcal). Visual analogue scales (VAS) were used to rate subjective appetite sensations. All assessments were conducted at baseline and after 8 weeks and 1 year of intervention. Whole‐body insulin sensitivity was unchanged 8 weeks after the intervention. One year after surgery, insulin sensitivity at both 20 and 80 mU/m2/min insulin infusion doses increased with BS weight loss (−33.8% ± 1.4% body weight) but was unchanged in LCD with small weight loss (−3.7% ± 2.0% body weight). Postprandial total PYY increased more following BS while total and acylated ghrelin decreased more following BS compared to LCD. Hunger decreased and fullness increased with BS compared to LCD (p = .037; p = .010, respectively). Insulin sensitivity was improved only 1 year after BS, despite significant weight loss after 8 weeks. Changes in gut peptides after BS paralleled reduced hunger and increased fullness. Most improvements in cardiometabolic health were related to weight loss.


  • Open Access

    A Pilot Feasibility Trial of Mind–Body Tactical Training for Firefighters: Evaluation of a Yoga-Based Transdiagnostic Program

    by Amanda J. Weathers-Meyer, Adam C. Lowe, Shelby J. McGrew, Nolynn E. Sutherland, Celeste M. G. Yann, Robbie A. Beyl, Anka A. Vujanovic


  • Effect of exercise training on insulin-stimulated glucose disposal: a systematic review and meta-analysis of randomized controlled trials

    by Candida J. Rebello, Dachuan Zhang, John P. Kirwan, Adam C. Lowe, Carlante J. Emerson, Chelsea L. Kracht, Lori C. Steib, Frank L. Greenway, William D. Johnson, Justin C. Brown

    Background and objective The effect of exercise training on whole-body insulin sensitivity has not been systematically summarized. We aimed to summarize the data from randomized controlled trials evaluating the effect of exercise training on insulin action, in adults. Subjects MEDLINE, EMBASE, and CENTRAL databases were searched until January 2021. Randomized controlled trials lasting ≥4 weeks, including adults, and evaluating the effect of exercise on insulin-stimulated glucose disposal measured using the hyperinsulinemic euglycemic clamp, were included. Methods Three reviewers extracted summary data from published trials. The primary outcome was insulin-stimulated glucose disposal. Standardized weighted mean differences (SMD) in glucose disposal between intervention and control were compared. The PEDro scale was used to assess risk of bias. Results We included 25 trials (36 interventions, N = 851). Exercise increased insulin-stimulated glucose disposal relative to control, SMD = 0.52 (95% confidence interval [CI]: 0.39, 0.65; p < 0.001; I2 = 47%) without significantly suppressing hepatic glucose production. In trials without isotopic tracers, exercise increased glucose disposal (SMD = 0.63; 95% CI: 0.48, 0.77; p < 0.001, I2 = 55%). In trials with isotopic tracers, exercise increased glucose disposal only when tracers were added to the exogenous glucose used for clamping (SMD = 0.34; 95% CI: 0.03, 0.66, p = 0.034. I2 = 0%). In a meta-regression model including aerobic exercise, weight change, and tracer technique, only percent weight change explained between trial heterogeneity (β = 0.069; 95% CI: 0.005, 0.013). The PEDro rating indicated relatively low risk of bias (5.8 ± 0.22). Conclusions Exercise training for at least four weeks significantly increases insulin-stimulated glucose disposal. Weight loss maximizes the effect and may be needed to improve hepatic insulin sensitivity. Differences in tracer methodology contribute to divergent outcomes and should be considered when assessing conclusions from research examining the effect of exercise on insulin action. Registration PROSPERO (CRD42019124381).